Monoclonal Antibodies: A Potential Solution For Prolonged COVID Symptoms?
Covid Lists
Long COVID: Some patients may need an immune system boost
Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research
Taurine deficiency as a driver of aging
Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19 | British Journal of Surgery | Oxford Academic
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
(16) Post-Viral Trials News (@postviraltrials) / X
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
Study Details | Antiviral Clinical Trial for Long Covid-19 | ClinicalTrials.gov
anticoagulant-triple-therapy.pdf
Archive - Studies, Surveys, & Supplements
RU2297846C2 - Method for treatment of focal and infiltrative pulmonary tuberculosis - Google Patents
Lives saved and lost in the first six month of the US COVID-19 pandemic: A retrospective cost-benefit analysis
Patient infected with COVID-19 finally cured after 411 days
Does Tenofovir Disoproxil Fumarate Mitigate COVID-19 Outcomes in Men with HIV?
Tenofovir and COVID: The Jury Is Still Out
Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
‘Old style’ tenofovir really may protect against COVID, large US study finds
Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV
Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B - BMC Infectious Diseases
Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients - BMC Infectious Diseases
Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study - BMC Infectious Diseases